How many acquisitions has Evotec made so far?

Evotec has completed 11 acquisitions so far, with an average acquisition amount of $73M.

Which countries does Evotec usually acquire in?

Evotec has made acquisitions in 6 countries with the most activity in United States and Germany.

Which is Evotec's latest acquisition?

Evotec's most recent acquisition is Central Glass, a Manufacturer and supplier of glasses, acquired in August 2022.

In which year did Evotec make the most acquisitions?

Evotec was most active in 2022, with 3 acquisitions completed in that year.

List of 11 Acquisitions by Evotec (Apr 2026)

Most viewed in 2019

Evotec has completed 11 acquisitions. Peak activity occurred in 2022 with 3 acquisitions, 2007 with 2, and 2019 with 1. The acquisitions spanned 6 countries, with most frequent activity in United States (3), Germany (3), and United Kingdom (2), and involved 8 distinct sectors, including Biopharma Outsourcing (5), Auto Components (1), and Diversified Pharmaceuticals (1). Over the last five years (2020–2025), the company averaged 0.6 acquisitions per year. No acquisitions have been completed in the current calendar year. The most recent acquisition was Central Glass, a manufacturer and supplier of glasses founded in 1936 and located in Chiyoda City, in August 2022.

Here's the year on year acquisition history of Evotec:

Number of Total Acquisitions

Year	# Acquisitions
2022	3
2019	1
2017	1
2016	1
2014	1
2011	1
2010	1
2007	2

View all Acquisitions by Evotec

Recent acquisitions by Evotec

Evotec's most recent acquisition - Central Glass is a Manufacturer and supplier of glasses, founded in 1936 and located in Chiyoda City. Evotec acquired it in August 2022.

Here is the list of all acquisitions by Evotec sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Aug 25, 2022	Central Glass	Undisclosed	-	20	225
Aug 25, 2022	Central Glass	Undisclosed	Ebner Stolz	45	335
May 30, 2022	Rigenerand	$24.7M	-	72	759
May 20, 2019	Just Biotherapeutics	Undisclosed	SRS Acquiom	54	113
Jul 30, 2017	Aptuit	$300M	Cain Brothers, William Blair	43	410